InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: DRG1025 post# 60077

Tuesday, 10/10/2017 12:57:58 PM

Tuesday, October 10, 2017 12:57:58 PM

Post# of 140474
I would think that if not before FDA, then shortly thereafter. If Titan builds momentum quickly, they are building value quickly and making a buyout much more expensive. Also, nobody really wants to go through a re-branding process; once units are out there in the field with the Titan name, does a buying organization want to replace them, re-label them... there are additional approvals for labels on a medical device, etc.

The tally so far is probably about where I would have expected. 13 contributors so far. Most gave a range, for which I took the mean value (if you said 8 to 10, I'm using 9 for your value). Others said things like anything over 5, so I'm calling it 5. The sum of these 13 values is 94.25, so the average is 7.25. If we were to act as a unified group, everyone would vote yes on a buyout of $7.25 per share. Given appx. 400M shares outstanding with warrants, that's $2.9B.

When we did the prior exercise to see how many shares we had cumulatively, we had 50 contributors, and there have been a number of new posters here since then. I'll keep tallying the numbers if more people respond.